Theraclion SA (EPA:ALTHE)

Theraclion Statistics

Total Valuation

Theraclion has a market cap or net worth of EUR 31.48 million. The enterprise value is 34.89 million.

Market Cap	31.48M
Enterprise Value	34.89M

Important Dates

The last earnings date was Wednesday, October 29, 2025.

Earnings Date	Oct 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Theraclion has 46.98 million shares outstanding. The number of shares has increased by 1.16% in one year.

Current Share Class	46.98M
Shares Outstanding	46.98M
Shares Change (YoY)	+1.16%
Shares Change (QoQ)	+2.59%
Owned by Insiders (%)	18.71%
Owned by Institutions (%)	6.93%
Float	24.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	37.92
PB Ratio	-276,139.20
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.06
EV / Sales	42.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-11.58

Financial Position

The company has a current ratio of 2.55

Current Ratio	2.55
Quick Ratio	1.87
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-2.52
Interest Coverage	-316.61

Financial Efficiency

Return on equity (ROE) is -203.90% and return on invested capital (ROIC) is -39.71%.

Return on Equity (ROE)	-203.90%
Return on Assets (ROA)	-28.29%
Return on Invested Capital (ROIC)	-39.71%
Return on Capital Employed (ROCE)	-82.96%
Revenue Per Employee	25,944
Profits Per Employee	-179,910
Employee Count	32
Asset Turnover	0.06
Inventory Turnover	1.80

Taxes

Income Tax	-983,691
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +76.32% in the last 52 weeks. The beta is -0.12, so Theraclion's price volatility has been lower than the market average.

Beta (5Y)	-0.12
52-Week Price Change	+76.32%
50-Day Moving Average	0.71
200-Day Moving Average	0.42
Relative Strength Index (RSI)	50.48
Average Volume (20 Days)	132,310

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Theraclion had revenue of EUR 830,209 and -5.76 million in losses. Loss per share was -0.12.

Revenue	830,209
Gross Profit	-3.83M
Operating Income	-6.82M
Pretax Income	-6.74M
Net Income	-5.76M
EBITDA	-6.50M
EBIT	-6.82M
Loss Per Share	-0.12

Balance Sheet

The company has 4.17 million in cash and 7.58 million in debt, giving a net cash position of -3.41 million or -0.07 per share.

Cash & Cash Equivalents	4.17M
Total Debt	7.58M
Net Cash	-3.41M
Net Cash Per Share	-0.07
Equity (Book Value)	-114
Book Value Per Share	-0.00
Working Capital	5.02M

Cash Flow

In the last 12 months, operating cash flow was -2.91 million and capital expenditures -102,000, giving a free cash flow of -3.01 million.

Operating Cash Flow	-2.91M
Capital Expenditures	-102,000
Free Cash Flow	-3.01M
FCF Per Share	-0.06

Margins

Gross Margin	n/a
Operating Margin	-821.37%
Pretax Margin	-811.94%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Theraclion does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.16%
Shareholder Yield	-1.16%
Earnings Yield	-18.29%
FCF Yield	-9.57%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Theraclion has an Altman Z-Score of -1.17 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.17
Piotroski F-Score	3